Health
Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Eli Lilly and Company (NYSE: LLY) today announced that Foundayo™ (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the U.S. Food and Drug Administration (FDA) approval on April 1, 2026. When used alongside a reduced-calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo is a once-daily pill for weight loss that can be taken without food or water restrictio
About this update from Eli Lilly And Company
[{"type":"text","content":"Foundayo is now available via LillyDirect® and telehealth providers and is shipping to retail pharmacies nationwide ","length":115,"tagName":"p","attribs":{}},{"type":"text","content":"Foundayo, the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions, starts at $25 per month with commercial coverage and $149 per month with self-pay","length":197,"tagName":"p","attribs":{}},{"type":"text","content":"INDIANAPOLIS, April 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Foundayo™ (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the U.S. Food and Drug Administration (FDA) approval on April 1, 2026. When used alongside a reduced-calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo is a once-daily pill for weight loss that can be taken without food or water restrictions. People can now access Foundayo via LillyDirect® and telehealth providers, with availability expanding to U.S. retail pharmacies beginning today.","length":692,"tagName":"p"},{"type":"text","content":""Foundayo delivers meaningful weight loss – an average of 27 pounds at the highest dose – and we made the path from prescription to doorstep as simple as possible," said Ilya Yuffa, executive vice president and president of Lilly USA and Global Customer Capabilities. "Millions of Americans can now connect with a health care professional to determine if Foundayo is right for them and receive the medicine at their door through LillyDirect's free home delivery, or access it through telehealth providers or local retail pharmacies."","length":557,"tagName":"p"},{"type":"text","content":"Foundayo is available starting at $149 per month at the lowest dose for self-pay patients.1 Eligible and commercially insured people with coverage for Foundayo may pay as little as $25 per month with the Foundayo savings card.2 Additionally, eligible Medicare Part D individuals may be able to get Foundayo for $50 per month, beginning July 1, 2026. To understand your options, visit www.foundayo.lilly.com.","length":407,"tagName":"p"},{"type":"text","content":"Supported by the rigorous ATTAIN clinical trial program, Foundayo was proven to help people los...